ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
다우존스 지수
38,686.32
1.51%
Bitcoin
67,532.78
0.08%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Acceleron Pharma Inc (XLRN)

  7. Acceleron Pharma Inc (XLRN) 뉴스

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:XLRN
일자시간출처헤드라인심볼기업
2021/12/0223:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2505:48Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2319:21TipRanksMerck Completes Acquisition of Acceleron PharmaNASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2223:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2222:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/2221:02Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/1804:26Business WireAvoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate OfferNASDAQ:XLRNAcceleron Pharma Inc
2021/11/1721:26Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/1721:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/1306:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/1221:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/1101:37Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/1007:31Business WireAvoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate OfferNASDAQ:XLRNAcceleron Pharma Inc
2021/11/0907:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/0907:15Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/0505:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/0505:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
2021/11/0505:01Business WireAcceleron Reports Third Quarter 2021 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
2021/10/2821:00Business WireAvoro Capital Issues Open Letter to Fellow Acceleron Pharma ShareholdersNASDAQ:XLRNAcceleron Pharma Inc
2021/10/2720:10Business WireAcceleron Announces Third Quarter 2021 REBLOZYL® Net SalesNASDAQ:XLRNAcceleron Pharma Inc
 검색 관련기사 보기:NASDAQ:XLRN

최근 히스토리

NYSE
AVDS
American Century
LSE
ST19
Citi Fun 25
BMF
BITM24
BITM24 - Junho 2024
BMF
WSPM24
WSPM24 - Junho 2024
LSE
DO1C
Comw.bk.a.31
COIN
X2Y2USD
X2Y2Token
ASX
ALD
Ampol
BOV
VALE3Q
VALE ON
COIN
EVERKRW
Everscale
TG
LMIA
Lion EMobility
BOV
WHRL4R
WHIRLPOOL PN
LSE
PZ44
Ab Dabi Dev.34s
USOTC
GDNGY
Gudang Garam TBK PT (PK)
LSE
BW63
Ab Inbev 44
NASDAQ
FWBXYX
Digital World Leaders St...
USOTC
BLTHD
American Battery Materials (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유